Globus Medical surpasses market expectations, driven by acquisitions
Globus Medical (NYSE: GMED) released fourth-quarter and full year 2025 results that exceeded Wall Street’s forecast, citing successful integration of NuVasive and Nervo and strong domestic spine sales growth. Globus Medical cites successful integration of …